Major depressive disorder is another name for depression. It can cause a persistent low mood, sleep disturbances, difficulty focusing, a loss of motivation, and other symptoms. A person with major ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults. This approval marks ...

In a recent study published in JAMA Psychiatry, researchers investigate whether reproducible signatures of metabolomic biomarkers could be obtained from dried blood spot samples to distinguish between ...

Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to difficulties in academic and professional life but also as a major cause of suicide in ...

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar depression. Clinical trials showed significant symptom improvement and potential ...

Share on Pinterest Emerging evidence suggests that a ketogenic diet could help support mental health. Alexander Spatari/Getty Images A new pilot study reports that young adults experienced a 70% ...